Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations

Clinical Transplantation

Volumn 28, Issue 4, 2014, Pages 410-418

  Wu, K Y ^a   Budde, K ^a   Schmidt, D ^a   Neumayer, H H ^a   Rudolph, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute cellular rejection; Graft outcome; Isolated v lesions; Kidney transplantation; Tubulointerstitial inflammation

Indexed keywords

ACUTE GRAFT REJECTION; ACUTE VASCULAR REJECTION; ADULT; ARTICLE; DISEASE SEVERITY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INFLAMMATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUBULOINTERSTITIAL INFLAMMATION; ACUTE DISEASE; ADOLESCENT; AGED; BIOPSY; DRUG COMBINATION; FEMALE; FOLLOW UP; GRAFT REJECTION; KAPLAN MEIER METHOD; KIDNEY; KIDNEY TUBULE; MALE; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899124015     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12333     Document Type: Article

References (16)

1. Mueller A, Schnuelle P, Waldherr R et al. Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation. Transplantation 2000: 69: 1123.
2. Finaly IM, Shaz A, Michael P et al. Banff criteria as predictors of outcome following acute renal allograft rejection. Nephrol Dial Transplant 1999: 14: 1692.
3. Minervini MI, Torbenson M, Scantlebury V et al. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade 1B). Am J Surg Pathol 2000: 24: 553.
4. Gaber LW, Moore LW, Gaber AO et al. Utility of standardized histological classification in the management of acute rejection 1995 Efficacy Endpoints Conference. Transplantation 1995: 65: 376.
5. Nickeleit V, Vamvakas EC, Pascual M et al. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998: 9: 1301.
6. Sis B, Mengel M, Haas M et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010: 10: 464.
7. Shimizu T, Tanabe T, Shirakawa H et al. Acute vascular rejection after renal transplantation and isolated lesion. Clin Transplant 2012: 26: 2.
8. Boom H, Mallat MJ, de Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000: 58: 859.
9. Dahan K, Audard V, Roudot-Thoraval F et al. Renal allograft biopsies with borderline changes: predictive factors of clinical outcome. Am J Transplant 2006: 6: 1725.
10. Liefeldt L, Brakemeier S, Glander P et al. Donor-specific HLA antibodies in a cohort comparing everolimus with Cyclosporine after kidney transplantation. Am J Transplant 2012: 12: 1192.
11. Gaber LW, Moore LW, Alloway RR et al. Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 1996: 49: 481.
12. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004: 351: 2751.
13. Meier-Kriesche HU, Schold J, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2006: 4: 378.
14. Salmela KT, von Willebrand EO, Kyllonen LEJ et al. Acute vascular rejection in renal transplantation-diagnosis and outcome. Transplantation 1992: 54: 858.
15. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931.
16. Matas AJ. Acute rejection is a major risk factor for chronic rejection. Transplant Proc 1998: 30: 1766.